Surgery Partners
SGRY
$15.80
+15.67%
Related headlines
SGRY price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Surgery Partners's 12-month outlook, with a consensus price target around $18.82 and implied upside of +19.1% versus the current price.
Average Target
$18.82
0 analysts
Implied Upside
+19.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$14 - $24
Analyst target range
SGRY Technical Analysis
Beta
1.92
1.92x market volatility
Max Drawdown
-51.8%
Largest decline past year
52-Week Range
$11-$23
Price range past year
Annual Return
-27.8%
Cumulative gain past year
| Period | SGRY Return | S&P 500 |
|---|---|---|
| 1m | +8.8% | +1.0% |
| 3m | +3.8% | +5.5% |
| 6m | +33.3% | +19.9% |
| 1y | -27.8% | +16.0% |
| ytd | +3.5% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is SGRY Overvalued?
PE
-25.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.2x
Enterprise Value Multiple